Articles with "pet tracers" as a keyword



Photo from wikipedia

Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework

Sign Up to like & get
recommendations!
Published in 2021 at "European Journal of Nuclear Medicine and Molecular Imaging"

DOI: 10.1007/s00259-020-05156-4

Abstract: In 2017, the Geneva Alzheimer’s disease (AD) strategic biomarker roadmap initiative proposed a framework of the systematic validation AD biomarkers to harmonize and accelerate their development and implementation in clinical practice. Here, we use this… read more here.

Keywords: tau pet; phase; pet tracers; validity ... See more keywords

Comparative Study of [18F]DPA714 and [18F]FDG PET Tracers in an Experimental Model of Pulmonary Tuberculosis.

Sign Up to like & get
recommendations!
Published in 2025 at "Molecular imaging and biology"

DOI: 10.1007/s11307-025-02057-6

Abstract: Tuberculosis (TB) continues to afflict global health. Therefore, a deeper understanding of the host response mechanisms that underly pathogenesis versus disease control upon infection with Mycobacterium tuberculosis (Mtb) is required to leverage the development of… read more here.

Keywords: 18f fdg; pet tracers; tuberculosis; 18f dpa714 ... See more keywords

Application of PET Tracers in Molecular Imaging for Breast Cancer

Sign Up to like & get
recommendations!
Published in 2020 at "Current Oncology Reports"

DOI: 10.1007/s11912-020-00940-9

Abstract: Purpose of Review Molecular imaging with positron emission tomography (PET) is a powerful tool to visualize breast cancer characteristics. Nonetheless, implementation of PET imaging into cancer care is challenging, and essential steps have been outlined… read more here.

Keywords: cancer; pet tracers; molecular imaging; breast cancer ... See more keywords
Photo from archive.org

Novel PET tracers: added value for endocrine disorders

Sign Up to like & get
recommendations!
Published in 2019 at "Endocrine"

DOI: 10.1007/s12020-019-01895-z

Abstract: SummaryNuclear medicine has been implicated in the diagnosis and treatment of endocrine disorders for several decades. With recent development of PET tracers, functional imaging now plays a major role in endocrine tumors enabling with high… read more here.

Keywords: pet tracers; endocrine disorders; added value; tracers added ... See more keywords
Photo from archive.org

Pet tracers for vulnerable plaque imaging

Sign Up to like & get
recommendations!
Published in 2020 at "Annals of Nuclear Medicine"

DOI: 10.1007/s12149-020-01458-7

Abstract: Most of the acute ischemic events, such as acute coronary syndromes and stroke, are attributed to vulnerable plaques. These lesions have common histological and pathophysiological features, including inflammatory cell infiltration, neo-angiogenesis, remodelling, haemorrhage predisposition, thin… read more here.

Keywords: pet tracers; pet; atherosclerotic plaques; vulnerable plaques ... See more keywords
Photo by impulsq from unsplash

Non-18F-Fluorodeoxyglucos PET Tracers in Pediatric Disease.

Sign Up to like & get
recommendations!
Published in 2020 at "PET clinics"

DOI: 10.1016/j.cpet.2020.03.013

Abstract: 18F-fluorodeoxyglucose (FDG) PET/computed tomography (CT) is an efficient method of diagnosing, staging, treatment evaluation, and recurrence monitoring of pediatric diseases. FDG has some limitations, but other PET/CT tracers have shown promising roles in evaluation of… read more here.

Keywords: pet tracers; pediatric disease; non 18f; 18f fluorodeoxyglucos ... See more keywords
Photo by impulsq from unsplash

A Critical Review of PET Tracers Used for Brain Tumor Imaging.

Sign Up to like & get
recommendations!
Published in 2021 at "PET clinics"

DOI: 10.1016/j.cpet.2020.12.004

Abstract: The brain is a common site for metastases as well as primary tumors. Although evaluation of these malignancies with contrast-enhanced MR imaging defines current clinical practice, 18F-fluorodeoxyglucose (FDG)-PET has shown considerable utility in this area.… read more here.

Keywords: pet tracers; tracers used; review pet; critical review ... See more keywords

New Long-Acting [89Zr]Zr-DFO GLP-1 PET Tracers with Increased Molar Activity and Reduced Kidney Accumulation.

Sign Up to like & get
recommendations!
Published in 2023 at "Journal of medicinal chemistry"

DOI: 10.1021/acs.jmedchem.2c02073

Abstract: Positron emission tomography (PET) imaging is used in drug development to noninvasively measure biodistribution and receptor occupancy. Ideally, PET tracers retain target binding and biodistribution properties of the investigated drug. Previously, we developed a zirconium-89… read more here.

Keywords: increased molar; kidney; pet tracers; molar activity ... See more keywords

Current Progress and Future Directions in Non-Alzheimer's Disease Tau PET Tracers.

Sign Up to like & get
recommendations!
Published in 2025 at "ACS chemical neuroscience"

DOI: 10.1021/acschemneuro.4c00319

Abstract: Alzheimer's disease (AD) and non-AD tauopathies are dominant public health issues driven by several factors, especially in the aging population. The discovery of first-generation radiotracers, including [18F]FDDNP, [11C]PBB3, [18F]flortaucipir, and the [18F]THK series, for the… read more here.

Keywords: disease; progress; pet tracers; tau pet ... See more keywords

Development of Novel PET Tracers for Imaging Non-AD Tauopathies.

Sign Up to like & get
recommendations!
Published in 2025 at "ACS medicinal chemistry letters"

DOI: 10.1021/acsmedchemlett.5c00487

Abstract: Tauopathies are a heterogeneous group of neurodegenerative diseases characterized by the pathological accumulation of microtubule-associated protein tau filaments in the brain. The development of tau-targeted positron emission tomography (PET) tracers has facilitated in vivo mapping… read more here.

Keywords: development; pet tracers; development novel; non tauopathies ... See more keywords

The 18-kDa Translocator Protein PET Tracers as a Diagnostic Marker for Neuroinflammation: Development and Current Standing

Sign Up to like & get
recommendations!
Published in 2022 at "ACS Omega"

DOI: 10.1021/acsomega.2c00588

Abstract: Translocator protein (TSPO, 18 kDa) is an evolutionary, well-preserved, and tryptophan-rich 169-amino-acid protein which localizes on the contact sites between the outer and inner mitochondrial membranes of steroid-synthesizing cells. This mitochondrial protein is implicated in… read more here.

Keywords: neuroinflammation; translocator protein; kda; pet tracers ... See more keywords